Lawrence E Bloch - President, Infinity Pharmaceuticals, Inc

As of June 14, 2019


Lawrence E Bloch Net Worth

  • Net worth is estimated to be at least $865.28K
  • Owns at least 589,903 units of Infinity Pharmaceuticals, Inc stock

Lawrence E Bloch Compensation at Infinity Pharmaceuticals, Inc in 2020

  • Earned a $488,014 salary and a $NaN bonus
  • Rewarded $103,946 in stock value and options
  • Received a total compensation of $1,813,353

Lawrence E Bloch Trading

  • Largest purchase of shares was 500,000 units , worth over $905K on December 7, 2017
  • In total has made about 11 transactions over 6 years
  • Usually trades in January, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Infinity Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Adelene Q. Perkins 2020 $689,585 $ $193,918 $1,399,928 $448,230 $11,429 $2,743,090
Adelene Q. Perkins 2019 $689,585 $61,250 - $552,480 $366,370 $11,172 $1,680,857
Lawrence E. Bloch, M.D., J.D. 2020 $488,014 $ $103,946 $966,961 $244,007 $10,425 $1,813,353
Lawrence E. Bloch, M.D., J.D. 2019 $488,014 - - $459,553 $204,235 $9,366 $1,161,168
Seth A. Tasker, J.D 2020 $386,159 $ $66,923 $818,913 $154,463 $8,986 $1,435,444
Seth A. Tasker, J.D 2019 $367,770 - - $138,012 $138,330 $8,820 $652,932
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1113148/000114036121014200/nc10021449x1_def14a.htm

Infinity Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 2,260,085 units sold on February 16, 2021 by Pil Partners Bvf, Fund Value Biotechnology, Bvf I GP Llc, Biotechnology Value Fund Ii Lp, Bvf Ii GP Llc, Biotechnology Value Trading Fund Os Lp, Bvf Partners Os Ltd, Bvf GP Holdings Llc, Incil Bvf and Mark Lampert worth over $12.13M
  • In the last 14 years, insiders at Infinity Pharmaceuticals, Inc sold an estimated value of $486.71M and bought an estimated value of $209.74M
  • The most active traders are Adelene Perkins, Chief Executive Officer,  Anthony B Evnin,  and Michael Venuti, Director
  • Insider trading is most common in January, with the busiest year in 2012

INFINITY PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1